Journal Description
Nutrients
Nutrients
is an international, peer-reviewed, open access journal of human nutrition published semimonthly online by MDPI. The Asia Pacific Nutrigenomics Nutrigenetics Organisation (APNNO), Italian Society for Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP), Nutrition Society of New Zealand (NSNZ), Ocular Wellness & Nutrition Society (OWNS) and others are affiliated with Nutrients and their members receive a discount on article processing charges.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, PubAg, AGRIS, and other databases.
- Journal Rank: JCR - Q1 (Nutrition and Dietetics) / CiteScore - Q1 (Food Science)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 13.5 days after submission; acceptance to publication is undertaken in 2.6 days (median values for papers published in this journal in the second half of 2024).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
- Companion journal: Dietetics
Impact Factor:
4.8 (2023);
5-Year Impact Factor:
5.8 (2023)
Latest Articles
Effect of Cashew Nut Consumption on Biomarkers of Copper and Zinc Status in Adolescents with Obesity: A Randomized Controlled Trial
Nutrients 2025, 17(1), 163; https://doi.org/10.3390/nu17010163 - 31 Dec 2024
Abstract
Background: Children and adolescents with obesity have altered serum copper (Cu) and zinc (Zn) levels, which are associated with oxidative stress, inflammation, and health outcomes. The inclusion of cashew nuts in an adequate diet may provide health benefits and help improve the mineral
[...] Read more.
Background: Children and adolescents with obesity have altered serum copper (Cu) and zinc (Zn) levels, which are associated with oxidative stress, inflammation, and health outcomes. The inclusion of cashew nuts in an adequate diet may provide health benefits and help improve the mineral status of individuals with obesity. Objective: To evaluate the effects of cashew nut consumption on biomarkers of Cu and Zn status in adolescents with obesity. Methods: This was a randomized controlled trial conducted in adolescents. The participants were divided into a control group (CON) and a cashew nut group (CASN). The CASN group received 30 g/day of roasted cashew nuts for 12 weeks, and both groups received nutritional counseling during the study. Anthropometric, dietary, and biochemical parameters (Zn, Cu, and superoxide dismutase (SOD)) were assessed at the baseline and at the end of the study. Association tests, within-group and between-group mean comparisons, and analyses of variation between study periods (Δ T12-T0) were performed. Results: The sample consisted of 81 adolescents who completed the intervention period, resulting in 54 in the CASN group and 27 in the CON group. After the intervention, the CASN group presented a decrease in plasma Cu (p = 0.004) and an increase in SOD (p = 0.030). Both groups showed an increase in plasma Zn (p < 0.050) and a decrease in the Cu/Zn ratio (p < 0.001). CASN had a negative effect on the Cu concentration, which was significantly different from that of CON (p = 0.004). Conclusions: The consumption of cashew nuts for 12 weeks reduced plasma Cu levels in adolescents with obesity. Nutritional counseling may have contributed to the increase in plasma Zn levels in all the study participants.
Full article
(This article belongs to the Section Micronutrients and Human Health)
Open AccessArticle
Growth, Safety and Tolerance in Infants Fed Rice Protein Hydrolysate Formula: The GRITO Randomised Controlled Trial
by
Anaïs Lemoine, Antonio Nieto-García, María Nieto-Cid, Beatriz Espín-Jaime, Ángel Mazón, Hocine Salhi, Dimitrios Salamouras, Nicolas Kalach, Roser de Castellar-Sansó, Jesús Delgado Ojeda and Víctor Manuel Navas-López
Nutrients 2025, 17(1), 162; https://doi.org/10.3390/nu17010162 - 31 Dec 2024
Abstract
Background: Hydrolysed rice formula (HRF) is tolerated by >90% of children with cow’s milk protein allergy (CMPA). However, concerns have been raised about potential suboptimal growth in infants fed HRF compared to those fed an extensively hydrolysed milk protein formula (eHF). Aims
[...] Read more.
Background: Hydrolysed rice formula (HRF) is tolerated by >90% of children with cow’s milk protein allergy (CMPA). However, concerns have been raised about potential suboptimal growth in infants fed HRF compared to those fed an extensively hydrolysed milk protein formula (eHF). Aims: To compare growth, safety and tolerance acquisition in infants with CMPA when fed HRF versus eHF. Methods: A multicentre prospective, randomised, double-blind, placebo-controlled food challenge trial was conducted with infants with CMPA. The infants received either HRF or eHF over a 12-month follow-up period. The primary outcome measure was the change from baseline over the study period in weight-for-length expressed as a Z-score. The secondary outcomes were other anthropometric measurements, tolerability and adverse events (AEs). Results: In total, 105 children were enrolled. The weight-for-length measurements were −0.01 (HRF) and −0.29 (eHF) at baseline and 0.29 and 0.05, respectively, at the last visit, with no significant between-group difference (p = 0.28; mixed-effects model). The Z-scores for other anthropometric variables indicated normal growth, with no significant between-group differences. In total, 29 potentially product-related AEs were reported (12 in the HRF group and 17 in the eHF group). A trend was observed toward a faster acquisition of tolerance in the HRF group (median age: 20.4 months) compared to the eHF group (16.3 months), but this was not statistically significant (p = 0.18). Conclusions: HRF demonstrated appropriate growth, acquisition of tolerance and a good safety profile in infants with CMPA, with no significant differences versus eHF. HRF could be considered as an appropriate option in the management of CMPA.
Full article
(This article belongs to the Special Issue The Nutritional Management of Food Allergy in Children)
►▼
Show Figures
Figure 1
Open AccessArticle
A Risk Score to Identify Low Bone Mineral Density for Age in Young Patients with Anorexia Nervosa
by
Laurent Maimoun, Helena Huguet, Eric Renard, Patrick Lefebvre, Maude Seneque, Laura Gaspari, Vincent Boudousq, Lisa Maimoun Nande, Philippe Courtet, Charles Sultan, Denis Mariano-Goulart, Marie-Christine Picot and Sebastien Guillaume
Nutrients 2025, 17(1), 161; https://doi.org/10.3390/nu17010161 - 31 Dec 2024
Abstract
Objective: Developing a scoring assessment tools for the determination of low bone mass for age at lumbar spine and hip in patients with anorexia nervosa (AN). Methods: The areal bone mineral density (aBMD) was determined with dual-energy X-ray absorptiometry (DXA). In 331 women
[...] Read more.
Objective: Developing a scoring assessment tools for the determination of low bone mass for age at lumbar spine and hip in patients with anorexia nervosa (AN). Methods: The areal bone mineral density (aBMD) was determined with dual-energy X-ray absorptiometry (DXA). In 331 women with AN and 121 controls, aged from 14.5 to 34.9 years, univariate and multivariate logistic regression analyses were performed to address the association of Z-score aBMD evaluated at lumbar spine and hip with several parameters. Results: For the lumbar spine and hip, the three risk factors significantly and independently associated with Z-score aBMD were age of patients (variable in class ≥20 yr vs. <20 yr), minimal disease-related BMI (continuous variable), and duration of amenorrhea without contraceptive use (variable in class ≥18 months vs. <18 months), with close values for the odds ratio for the two bone sites. A simple risk score equation was developed and tested combining only these three parameters. The AUC's measuring the score’s performance were, respectively, 0.85 [95% CI: 0.79–0.90] with a sensitivity of 83% and specificity of 71%, and 0.82 [95% CI: 0.76–0.86] with a sensitivity of 92% and specificity of 55% to detect low aBMD in lumbar spine and hip. The cut-off values for low bone mass for age were 0.9 and 1.33 for the two bone sites. The prediction model revealed that a minimum of 83% of the patients presenting low bone mass for age were correctly identified. Conclusions: the study presents for the first time a risk score for diagnosing low bone mass for age in young patients with AN. Considering its excellent sensitivity, and its ease of use, requiring only three parameters that are well identified in this disease, this new score may be useful in clinical settings when DXA scans are not feasible.
Full article
(This article belongs to the Special Issue Advances in Eating Disorders in Children and Adolescents)
Open AccessArticle
Tremella fuciformis Berk Alleviated Atherosclerosis Symptoms via Nuclear Factor-Kappa B-Mediated Inflammatory Response in ApoE−/− Mice
by
Yihao Dong, Qinchun Zhang, Rui Xie, Jundi Zhao, Zhihua Han, Yu Li, Han Yu and Yongfeng Zhang
Nutrients 2025, 17(1), 160; https://doi.org/10.3390/nu17010160 - 31 Dec 2024
Abstract
Background: Atherosclerosis, a persistent inflammatory disease marked by the presence of atherosclerotic plaques or fibrous plaques, is a significant contributor to the onset of the development of cardiovascular disease. Tremella fuciformis Berk contains various active ingredients that have anti-inflammatory, antioxidant, and hypolipidemic properties.
[...] Read more.
Background: Atherosclerosis, a persistent inflammatory disease marked by the presence of atherosclerotic plaques or fibrous plaques, is a significant contributor to the onset of the development of cardiovascular disease. Tremella fuciformis Berk contains various active ingredients that have anti-inflammatory, antioxidant, and hypolipidemic properties. Nevertheless, the potential effects of T. fuciformis on atherosclerosis have not been systematically reported. Method: In this study, ApoE−/− mice were employed as models of atherosclerosis caused by a high-fat diet (HFD) to investigate the effect of T. fuciformis. Gut microbiota and serum metabolism analysis were performed to elucidate the potential mechanism of T. fuciformis for its anti-atherosclerosis effects. Results: T. fuciformis significantly decreased the aortic root wall thickness and the area of lipid droplets, regulated lipid levels, and inhibited fat accumulation to improve aortic root lesions. Furthermore, T. fuciformis significantly altered serum metabolite (including diethyl phthalate and succinate) levels, regulated the abundance of microbiota, such as Coriobacteriaceae_UCG-002 and Alistipes, and suppressed the inflammatory response to ameliorate atherosclerosis via the nuclear factor-kappa B (NF-κB)-mediated inflammatory response in HFD-induced ApoE−/− mice. Conclusions: These results offer a theoretical basis and data to support T. fuciformis as a potential strategy for treating atherosclerosis.
Full article
(This article belongs to the Special Issue Functional Evaluation of Edible Mushrooms and Their Active Materials)
Open AccessArticle
Association Between Serum Folate Concentrations and 10-Year Stroke Risk in a Prospective Community Cohort: Mediation and Interaction Analyses
by
Zhe Liang, Fangfang Fan, Bo Liu, Kaiyin Li, Hongyu Chen, Jia Jia, Yong Huo, Jianping Li and Yan Zhang
Nutrients 2025, 17(1), 159; https://doi.org/10.3390/nu17010159 - 31 Dec 2024
Abstract
The relationship between folate concentrations and stroke risk remains unestablished, and the mediation effect of homocysteine (Hcy) and interaction effect of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism has yet to be investigated. This cohort study involved 4903 subjects derived from a
[...] Read more.
The relationship between folate concentrations and stroke risk remains unestablished, and the mediation effect of homocysteine (Hcy) and interaction effect of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism has yet to be investigated. This cohort study involved 4903 subjects derived from a Chinese community population. The association between folate and first stroke was examined in Cox proportional hazard regression models. The mediation analyses involving Hcy and the undiscovered modification of the MTHFR C677T genotype were assessed. The mean (SD) age of subjects was 56.7 (8.8) years old, and 37.0% were male. A total of 407 strokes, 375 ischemic strokes and 47 hemorrhagic strokes occurred during the mean (SD) follow-up of 9.3 (1.8) years. The participants in the highest folate quartile (≥8.2 ng/mL) exhibited a lower stroke risk compared to those in the lowest quartile (hazard ratio [HR]: 0.68, 95% confidence interval [CI]: 0.50–0.93, p = 0.017; p for trend = 0.009). Hcy significantly mediated 14.51% of the relationship between folate and stroke in the fully adjusted model. Only in individuals with the MTHFR 677CC genotype but not CT/TT genotype was folate adversely correlated with stroke (HR: 0.88, 95% CI: 0.79–0.97, p for interaction = 0.026) and ischemic stroke (HR: 0.88, 95% CI: 0.80–0.98, p for interaction = 0.035). Insufficient folate concentrations were associated with a heightened 10-year stroke risk, in which Hcy concentrations played a crucial mediating role. MTHFR C677T gene polymorphism could potentially modify the folate–stroke relationship.
Full article
(This article belongs to the Section Nutritional Epidemiology)
Open AccessArticle
Effects of a Rosmarinus officinalis L. Extract and Rosmarinic Acid in Improving Streptozotocin-Induced Aortic Tissue Damages in Rats
by
Irina Ielciu, Gabriela Adriana Filip, Alexandra C. Sevastre-Berghian, Ioana Bâldea, Neli-Kinga Olah, Ramona Flavia Burtescu, Vlad Alexandru Toma, Remus Moldovan, Ilioara Oniga and Daniela Hanganu
Nutrients 2025, 17(1), 158; https://doi.org/10.3390/nu17010158 - 31 Dec 2024
Abstract
Background/Aim: Rosmarinus officinalis L. (R. officinalis) is an aromatic medicinal species with important nutraceutical potential, having rosmarinic acid (RA) as one of its main metabolites. The present study aims to evaluate the effects of an extract obtained from the leaves of
[...] Read more.
Background/Aim: Rosmarinus officinalis L. (R. officinalis) is an aromatic medicinal species with important nutraceutical potential, having rosmarinic acid (RA) as one of its main metabolites. The present study aims to evaluate the effects of an extract obtained from the leaves of this species and of its main metabolite in improving the streptozotocin-induced damage of hearts and aorta of diabetic rats. Methods: The leaves of the species were used to obtain a hydroethanolic extract, which was analyzed using the LC/MS method. Diabetes mellitus was induced by intraperitoneal streptozotocin administration in rats. After two weeks, oxidative stress parameters were evaluated from the heart and aorta homogenates. NOS3, AMPK, and adiponectin levels were quantified using ELISA tests, and thoracic aorta rings were isolated for contractility evaluation in the organ bath. Phospho-NF-κB, NRF2, HIF1 alfa, iNOS, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) quantification were performed using the Western blot technique. Results: Carnosic acid, together with rosmarinic acid, were proven to be the main metabolites identified in the composition of the tested extract. Administration of the extract and of RA improved the relaxation response to acetylcholine and the redox status, with the reduction in malondialdehyde (MDA), nitric oxide synthase 3 (NOS 3), AMP-activated protein kinase (AMPK), adiponectin, reduced (GSH) and oxidized glutathione (GSSG) levels, and superoxide dismutase (SOD) activity. RA significantly enhanced the expression of HIF 1α, NRF2, and pNFkB in the heart. Conclusions: Administration of the R. officinalis extract and of RA-alleviated oxidative stress, proving vascular and cardiac antioxidant properties in the hearts and aorta of diabetic rats.
Full article
(This article belongs to the Section Clinical Nutrition)
Open AccessArticle
Chronobiological Factors Influencing Glycemic Control and Birth Outcomes in Gestational Diabetes Mellitus
by
Amalia Messika, Yoel Toledano, Eran Hadar, Riva Tauman, Oren Froy and Raanan Shamir
Nutrients 2025, 17(1), 157; https://doi.org/10.3390/nu17010157 - 31 Dec 2024
Abstract
Background/Objectives: Studies have shown that chronobiological factors may adversely affect glycemic control in patients with type 2 diabetes mellitus. We assessed the association of chronobiological factors with glycemic control and neonatal birth weight in women with GDM. Methods: A prospective cohort study included
[...] Read more.
Background/Objectives: Studies have shown that chronobiological factors may adversely affect glycemic control in patients with type 2 diabetes mellitus. We assessed the association of chronobiological factors with glycemic control and neonatal birth weight in women with GDM. Methods: A prospective cohort study included 208 women aged 18–45 years with a singleton pregnancy who were randomly selected from among women undergoing follow-up for GDM at the Maternal-Fetal Medicine Unit of a tertiary medical center. Nutrition, sleep, and lifestyle patterns were assessed from onset of GDM until birth along with glycemic control and birth outcomes. Results: Multivariate analyses on a cohort of 208 women revealed that suboptimal glycemic control was associated with a late breakfast (RR = 2.26; 95% CI 1.09–4.67), increased carbohydrate intake in the evening (RR = 1.19; 95% CI 1.003–1.42), and poor sleep quality (RR = 2.14; 95% CI 1.04–4.41). The adjusted relative risk for neonatal birth weight above the 85th percentile was associated with increased carbohydrate intake in the morning (RR = 1.70; 95%CI 1.30–2.23) and increased carbohydrate intake in the evening (RR = 1.39; 95% CI 1.16–1.67). Conclusions: Chronobiological factors are associated with suboptimal glycemic control and birth weight above the 85th percentile in women with GDM. The study was registered under ClinicalTrials.gov.org, identifier: NCT02916667.
Full article
(This article belongs to the Special Issue Nutrition Intervention in Glycaemic Control and Diabetes)
Open AccessReview
Vitamin D Supplementation in Critically Ill—Narrative Review
by
Lenko Saric, Josipa Domazet Bugarin and Svjetlana Dosenovic
Nutrients 2025, 17(1), 156; https://doi.org/10.3390/nu17010156 - 31 Dec 2024
Abstract
Background: Studies have shown a high prevalence of vitamin D deficiency in critically ill patients, and these patients are at higher risk for pneumonia and have increased incidence of sepsis and mortality. In this study, we reviewed available literature from randomized controlled trials
[...] Read more.
Background: Studies have shown a high prevalence of vitamin D deficiency in critically ill patients, and these patients are at higher risk for pneumonia and have increased incidence of sepsis and mortality. In this study, we reviewed available literature from randomized controlled trials (RCTs) on vitamin D supplementation in critically ill patients and summarized the evidence in this narrative review. Methods: Randomized controlled trials that included vitamin D supplementation as an intervention were eligible for inclusion. No limits were set regarding vitamin D dosage or route of administration, as well as for primary and secondary outcomes. A search was conducted in MEDLINE via PubMed for eligible RCTs. References from systematic reviews (SRs) and meta-analyses (MAs) were screened, and Clinicaltrials.gov was searched for ongoing studies. Results: A total of 21 RCTs involving 3166 patients were analyzed. There was a large heterogeneity in terms of patients’ characteristics and inclusion criteria. Only six studies included patients with vitamin D levels < 50 nmol/L. Regarding clinically important outcomes, most of the studies did not show differences between the intervention and control group in terms of mortality, intensive care unit (ICU) or hospital length of stay (LoS). Conclusions: There is great variability in trial designs regarding the selection of patients, dosage, dosing intervals and routes of administration of vitamin D supplements. Better study designs are mandatory for future clinical research, with measuring and reporting basal vitamin D levels before randomization. Since variability in supplementation regimes limits the possibility of data synthesis, standardized protocols for vitamin D supplementation should be used in clinical trial settings.
Full article
(This article belongs to the Section Clinical Nutrition)
Open AccessReview
Exploring Gut Microbiota Imbalance in Irritable Bowel Syndrome: Potential Therapeutic Effects of Probiotics and Their Metabolites
by
María José García Mansilla, María Jesús Rodríguez Sojo, Andrea Roxana Lista, Ciskey Vanessa Ayala Mosqueda, Antonio Jesús Ruiz Malagón, Julio Gálvez, Alba Rodríguez Nogales and María José Rodríguez Sánchez
Nutrients 2025, 17(1), 155; https://doi.org/10.3390/nu17010155 - 31 Dec 2024
Abstract
Irritable bowel syndrome is a common functional gastrointestinal disorder characterized by recurrent abdominal discomfort, bloating, cramping, flatulence, and changes in bowel movements. The pathophysiology of IBS involves a complex interaction between motor, sensory, microbiological, immunological, and psychological factors. Diversity, stability, and metabolic activity
[...] Read more.
Irritable bowel syndrome is a common functional gastrointestinal disorder characterized by recurrent abdominal discomfort, bloating, cramping, flatulence, and changes in bowel movements. The pathophysiology of IBS involves a complex interaction between motor, sensory, microbiological, immunological, and psychological factors. Diversity, stability, and metabolic activity of the gut microbiota are frequently altered in IBS, thus leading to a situation of gut dysbiosis. Therefore, the use of probiotics and probiotic-derived metabolites may be helpful in balancing the gut microbiota and alleviating irritable bowel syndrome symptoms. This review aimed to report and consolidate recent progress in understanding the role of gut dysbiosis in the pathophysiology of IBS, as well as the current studies that have focused on the use of probiotics and their metabolites, providing a foundation for their potential beneficial effects as a complementary and alternative therapeutic strategy for this condition due to the current absence of effective and safe treatments.
Full article
(This article belongs to the Special Issue Probiotics and Their Metabolites in Human Health)
►▼
Show Figures
Figure 1
Open AccessArticle
The Impacts of Programs and Policies to Address Food Insecurity: An Analysis of Change in Income
by
Eva Nelson, Jacqueline Milton Hicks, Lok Hang Kristina Keung, Elizabeth Rhoades, Jemima Mascary and Jacey A. Greece
Nutrients 2025, 17(1), 154; https://doi.org/10.3390/nu17010154 - 31 Dec 2024
Abstract
Background/Objectives: This paper examines hunger over time to analyze how food insecurity is impacted by reduced income, including household funding from the government. Federal policies and community-based programs have the ability to prevent increases in food insecurity, particularly for populations that have risk
[...] Read more.
Background/Objectives: This paper examines hunger over time to analyze how food insecurity is impacted by reduced income, including household funding from the government. Federal policies and community-based programs have the ability to prevent increases in food insecurity, particularly for populations that have risk factors, such as households with children; single-parent households; low-income households, especially those in rural areas; Black and Hispanic households; and, households experiencing economic hardships. Methods: This study is bas ed on a cross-sectional survey that was administered in 2018 and 2019 to food pantry clients, an already food insecure population accessing resources, in Eastern Massachusetts. Baseline surveys were matched with a 3-month follow-up survey (n = 308) and multinomial logistic mixed effect models were used to analyze the association between change in household hunger and change in household income. Results: This study found that participants who experienced decreased income compared to no income change from baseline to follow-up had 2.16 times the odds (95% CI: 1.05, 4.46) of experiencing increased household hunger compared to no change in hunger from baseline to follow-up, after adjusting for all other covariates. Conclusions: Food insecurity in the United States remained stable during the beginning of COVID-19, despite prevalence of reduced household income. The expanded government benefits that were implemented early in the pandemic contributed to total household income, which prevented increased food insecurity. Increased food insecurity after the removal of benefits starting in 2022 indicates the importance of continuing support established during times when consistent income is compromised to prevent a delayed rise in food insecurity.
Full article
(This article belongs to the Special Issue Community-Engaged Strategies to Improve Food Access, Food Security, and Health Outcomes)
Open AccessArticle
Association of Serum Polyunsaturated Fatty Acids (PUFAs) and Children’s Dietary Inflammatory Index (C-DIITM) with Recurrent Respiratory Infections in Children: A Cross-Sectional Study
by
Daiva Gorczyca, Karolina Szeremeta, Mariola Paściak, Bogumiła Szponar, Longgang Zhao, Michael D. Wirth, James R. Hebert, Natalia Związek and Anna Prescha
Nutrients 2025, 17(1), 153; https://doi.org/10.3390/nu17010153 - 31 Dec 2024
Abstract
To assess the associations between serum and dietary polyunsaturated fatty acids (PUFAs), as well as the inflammatory potential of diet measured by the Children’s Dietary Inflammatory Index (C-DIITM), and recurrent respiratory infections (RRIs) in children. We enrolled 44 children aged 3–16
[...] Read more.
To assess the associations between serum and dietary polyunsaturated fatty acids (PUFAs), as well as the inflammatory potential of diet measured by the Children’s Dietary Inflammatory Index (C-DIITM), and recurrent respiratory infections (RRIs) in children. We enrolled 44 children aged 3–16 years with RRIs and 44 healthy controls. Dietary intake was assessed using a 7-day food record from which PUFA intake and C-DIITM were calculated. Serum PUFA levels were determined using gas–liquid chromatography–mass spectrometry. The dietary assessment showed a significantly lower fiber intake in children with RRIs. The RRI group had a higher inflammatory potential in the diet than healthy controls. Children with RRIs have higher serum levels of linoleic, arachidonic, and eicosapentaenoic acids than healthy subjects. A pro-inflammatory diet was positively associated with serum n-6 PUFA levels in both the groups. A high inflammatory potential of diet, body mass index over 75 percentile, and short breastfeeding duration were identified as risk factors for RRIs. The inflammatory potential of diet is strongly associated with RRIs in children and related to their PUFA status. Promoting breastfeeding and healthy dietary habits during childhood are crucial for implementing effective preventive management strategies.
Full article
(This article belongs to the Section Pediatric Nutrition)
►▼
Show Figures
Figure 1
Open AccessArticle
Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression
by
Long Teng, Ling Luo, Yanhong Sun, Wei Wang, Zhi Dong, Xiaopei Cao, Junzhao Ye and Bihui Zhong
Nutrients 2025, 17(1), 152; https://doi.org/10.3390/nu17010152 - 31 Dec 2024
Abstract
Background: The 1-h post-load plasma glucose was proposed to replace the current OGTT criteria for diagnosing prediabetes/diabetes. However, it remains unclear whether it is superior in identifying progressive metabolic dysfunction-associated steatotic liver disease (MASLD), and thus we aimed to clarify this issue.
[...] Read more.
Background: The 1-h post-load plasma glucose was proposed to replace the current OGTT criteria for diagnosing prediabetes/diabetes. However, it remains unclear whether it is superior in identifying progressive metabolic dysfunction-associated steatotic liver disease (MASLD), and thus we aimed to clarify this issue. Methods: Consecutive Asian participants (non-MASLD, n = 1049; MASLD, n = 1165) were retrospectively enrolled between June 2012 and June 2024. CT was used to quantify liver steatosis, while the serum liver fibrotic marker was used to evaluate liver fibrosis. Results: Compared with those with normal levels of both 1-h post-glucose (1hPG) and 2-h post-glucose (2hPG), patients with MASLD showed a significant positive association between elevated 1hPG levels and moderate to severe liver steatosis (odds ratio [OR] = 2.19, 95% confidence interval [CI]: 1.13–4.25, p = 0.02]. Elevated levels of both 1hPG and 2hPG were associated with an increased risk of liver injury (OR = 2.03, 95% CI: 1.44–2.86, p < 0.001). Elevated 2hPG levels with or without elevated 1hPG levels were associated with liver fibrosis (OR = 1.99, 95% CI: 1.15–3.45, p < 0.001; OR = 2.72, 95% CI: 1.79–4.11, p < 0.001, respectively). Additionally, either 1hPG or 2hPG levels were associated with atherosclerosis, revealing significant dose-dependent associations between glucose status and atherosclerosis risk (OR = 2.77, 95% CI: 1.55–4.96, p < 0.001 for elevated 1hPG; OR = 2.98, 95% CI = 1.54–5.78, p = 0.001 for elevated 2hPG; OR = 2.41, 95% CI = 1.38–4.21, p = 0.001 for elevated levels of both 1hPG and 2hPG). The areas under the ROC for predicting steatosis, liver injury, liver fibrosis, and atherosclerosis were 0.64, 0.58, 0.58, and 0.64 for elevated 1hPG (all p < 0.05) and 0.50, 0.60, 0.56, and 0.62 for elevated 2hPG (all p < 0.05), respectively. Conclusions: These findings underscore the necessity for clinicians to acknowledge that the screening and management of MALSD requires the monitoring of 1hPG levels.
Full article
(This article belongs to the Section Nutrition and Diabetes)
►▼
Show Figures
Figure 1
Open AccessArticle
The Bifidogenic Effect of 2’Fucosyllactose Is Driven by Age-Specific Bifidobacterium Species, Demonstrating Age as an Important Factor for Gut Microbiome _targeted Precision Medicine
by
Jenni Firrman, Stef Deyaert, Karley K. Mahalak, LinShu Liu, Aurélien Baudot, Marie Joossens, Jonas Poppe, Simon J. S. Cameron and Pieter Van den Abbeele
Nutrients 2025, 17(1), 151; https://doi.org/10.3390/nu17010151 - 31 Dec 2024
Abstract
Background: The human gut microbiota develops in concordance with its host over a lifetime, resulting in age-related shifts in community structure and metabolic function. Little is known about whether these changes impact the community’s response to microbiome-_targeted therapeutics. Providing critical information on this
[...] Read more.
Background: The human gut microbiota develops in concordance with its host over a lifetime, resulting in age-related shifts in community structure and metabolic function. Little is known about whether these changes impact the community’s response to microbiome-_targeted therapeutics. Providing critical information on this subject, faecal microbiomes of subjects from six age groups, spanning from infancy to 70-year-old adults (n = six per age group) were harvested. The responses of these divergent communities to treatment with the human milk oligosaccharide 2’-fucosyllactose (2’FL), fructo-oligosaccharides (FOS), and lactose was investigated using the Ex vivo SIFR® technology that employs bioreactor fermentation and is validated to be predictive of clinical findings. Additionally, it was evaluated whether combining faecal microbiomes of a given age group into a single pooled microbiome produced similar results as the individual microbiomes. Results: First, marked age-dependent changes in community structure were identified. Bifidobacterium levels strongly declined as age increased, and Bifidobacterium species composition was age-dependent: B. longum, B. catenulatum/pseudocatenulatum, and B. adolescentis were most prevalent for breastfed infants, toddlers/children, and adults, respectively. Metabolomic analyses (LA-REIMS) demonstrated that these age-dependent differences particularly impacted treatment effects of 2’FL (more than FOS/lactose). Further analysis revealed that while 2’FL enhanced production of short-chain fatty acids (SCFAs) and exerted potent bifidogenic effects, regardless of age, the specific Bifidobacterium species enhanced by 2’FL, as well as subsequent cross-feeding interactions, were highly age-dependent. Furthermore, single-pooled microbiomes produced results that were indicative of the average treatment response for each age group. Nevertheless, pooled microbiomes had an artificially high diversity, thus overestimating treatment responses (especially for infants), did not recapitulate interindividual variation, and disallowed for the correlative analysis required to unravel mechanistic actions. Conclusions: Age is an important factor in shaping the gut microbiome, with the dominant taxa and their metabolites changing over a lifetime. This divergence affects the response of the microbiota to therapeutics, demonstrated in this study using 2’FL. These results evidence the importance of screening across multiple age groups separately to provide granularity of how therapeutics impact the microbiome and, consequently, human health.
Full article
(This article belongs to the Special Issue Effects of Probiotics, Prebiotics, and Postbiotics on Human Health)
►▼
Show Figures
Figure 1
Open AccessArticle
Cell Membrane Fatty Acids and PIPs Modulate the Etiology of Pancreatic Cancer by Regulating AKT
by
Carolina Torres, Georgina Mancinelli, Jee-Wei Emily Chen, Jose Cordoba-Chacon, Danielle Pins, Sara Saeed, Ronald McKinney, Karla Castellanos, Giulia Orsi, Megha Singhal, Akshar Patel, Jose Acebedo, Adonis Coleman, Jorge Heneche, Poorna Chandra Rao Yalagala, Papasani V. Subbaiah, Cecilia Leal, Sam Grimaldo, Francisco M. Ortuno, Faraz Bishehsari and Paul J. Grippoadd
Show full author list
remove
Hide full author list
Nutrients 2025, 17(1), 150; https://doi.org/10.3390/nu17010150 - 31 Dec 2024
Abstract
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the worst solid malignancies in regard to outcomes and metabolic dysfunction leading to cachexia. It is alarming that PDAC incidence rates continue to increase and warrant the need for innovative approaches to combat this disease.
[...] Read more.
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the worst solid malignancies in regard to outcomes and metabolic dysfunction leading to cachexia. It is alarming that PDAC incidence rates continue to increase and warrant the need for innovative approaches to combat this disease. Due to its relatively slow progression (10–20 years), prevention strategies represent an effective means to improve outcomes. One of the risk factors for many cancers and for pancreatic cancer in particular is diet. Hence, our objective is to understand how a diet rich in ω3 and ω6 polyunsaturated fatty acids affects the progression of this disease. Methods: We investigated polyunsaturated fatty acid (PUFA) effects on disease progression employing both in vitro (PDAC cell lines) and in vivo (EL-Kras and KC mice) approaches. Also, we gathered data from the National Health and Nutrition Examination Survey (NHANES) and the National Cancer Institute (NCI) from 1999 to 2017 for a retrospective observational study. Results: The consumption of PUFAs in a patient population correlates with increased PDAC incidence, particularly when the ω3 intake increases to a lesser extent than ω6. Our data demonstrate dietary PUFAs can be incorporated into plasma membrane lipids affecting PI3K/AKT signaling and support the emergence of membrane-_targeted therapies. Moreover, we show that the phospholipid composition of a lipid nanoparticle (LNP) can impact the cell membrane integrity and, ultimately, cell viability after administration of these LNPs. Conclusions: Cancer prevention is impactful particularly for those with very poor prognosis, including pancreatic cancer. Our results point to the importance of dietary intervention in this disease when detected early and the potential to improve the antiproliferative effect of drug efficacy when combined with these regimens in later stages of pancreatic cancer.
Full article
(This article belongs to the Section Nutritional Epidemiology)
►▼
Show Figures
Figure 1
Open AccessArticle
DAG-MAG-ΒHB: A Novel Ketone Diester Modulates NLRP3 Inflammasome Activation in Microglial Cells in Response to Beta-Amyloid and Low Glucose AD-like Conditions
by
Valentina Gentili, Giovanna Schiuma, Latha Nagamani Dilliraj, Silvia Beltrami, Sabrina Rizzo, Djidjell Lara, Pier Paolo Giovannini, Matteo Marti, Daria Bortolotti, Claudio Trapella, Marco Narducci and Roberta Rizzo
Nutrients 2025, 17(1), 149; https://doi.org/10.3390/nu17010149 - 31 Dec 2024
Abstract
Background: A neuroinflammatory disease such as Alzheimer’s disease, presents a significant challenge in neurotherapeutics, particularly due to the complex etiology and allostatic factors, referred to as CNS stressors, that accelerate the development and progression of the disease. These CNS stressors include cerebral hypo-glucose
[...] Read more.
Background: A neuroinflammatory disease such as Alzheimer’s disease, presents a significant challenge in neurotherapeutics, particularly due to the complex etiology and allostatic factors, referred to as CNS stressors, that accelerate the development and progression of the disease. These CNS stressors include cerebral hypo-glucose metabolism, hyperinsulinemia, mitochondrial dysfunction, oxidative stress, impairment of neuronal autophagy, hypoxic insults and neuroinflammation. This study aims to explore the efficacy and safety of DAG-MAG-ΒHB, a novel ketone diester, in mitigating these risk factors by sustaining therapeutic ketosis, independent of conventional metabolic pathways. Methods: We evaluated the intestinal absorption of DAG-MAG-ΒHB and the metabolic impact in human microglial cells. Utilizing the HMC3 human microglia cell line, we examined the compound’s effect on cellular viability, Acetyl-CoA and ATP levels, and key metabolic enzymes under hypoglycemia. Additionally, we assessed the impact of DAG-AG-ΒHB on inflammasome activation, mitochondrial activity, ROS levels, inflammation and phagocytic rates. Results: DAG-MAG-ΒHB showed a high rate of intestinal absorption and no cytotoxic effect. In vitro, DAG-MAG-ΒHB enhanced cell viability, preserved morphological integrity, and maintained elevated Acetyl-CoA and ATP levels under hypoglycemic conditions. DAG-MAG-ΒHB increased the activity of BDH1 and SCOT, indicating ATP production via a ketolytic pathway. DAG-MAG-ΒHB showed remarkable resilience against low glucose condition by inhibiting NLRP3 inflammasome activation. Conclusions: In summary, DAG-MAG-ΒHB emerges as a promising treatment for neuroinflammatory conditions. It enhances cellular health under varying metabolic states and exhibits neuroprotective properties against low glucose conditions. These attributes indicate its potential as an effective component in managing neuroinflammatory diseases, addressing their complex progression.
Full article
(This article belongs to the Section Nutrition and Neuro Sciences)
►▼
Show Figures
Graphical abstract
Open AccessArticle
The Association of Sodium or Potassium Intake Timing with Athens Insomnia Scale Scores: A Cross-Sectional Study
by
Taiki Okamoto, Yun-Peng Lo, Inn-Kynn Khaing, Shoko Inoue, Ayako Tada, Mikiko Michie, Tatsuhiko Kubo, Shigenobu Shibata and Yu Tahara
Nutrients 2025, 17(1), 148; https://doi.org/10.3390/nu17010148 - 31 Dec 2024
Abstract
Background/Objectives: Insomnia is a significant public health problem affecting a large population. Although previous research has explored the relationship between specific nutrients and insomnia, comprehensive analyses of daily eating patterns of macro- and micronutrients remain limited. Since nocturnal hypertension is related to sodium/potassium
[...] Read more.
Background/Objectives: Insomnia is a significant public health problem affecting a large population. Although previous research has explored the relationship between specific nutrients and insomnia, comprehensive analyses of daily eating patterns of macro- and micronutrients remain limited. Since nocturnal hypertension is related to sodium/potassium intake and sleep disturbances, the present cross-sectional study hypothesized that daily eating patterns of potassium and sodium would be associated with Athens Insomnia Scale (AIS) scores. Methods: Dietary data (breakfast, lunch, dinner, and snack intake) and additional online questionnaire responses were obtained from users (N = 4568; age: 43.5 ± 11.2 years) of Asken, a Japanese food-logging mobile health application. AIS scores were divided into three groups according to symptom classification. Results: Multiple regression analyses revealed that individuals with higher AIS scores had higher daily potassium intake; potassium at dinner was especially crucial. Conclusions: These results underscore the potential importance of potassium intake in relation to sleep and highlight a novel association between sleep disturbances and the timing of sodium and potassium consumption.
Full article
(This article belongs to the Special Issue Chrono-Nutrition and Human Health)
Open AccessArticle
Diet and Lifestyle Factors and Incident Acute Mesenteric Ischemia—A Prospective Cohort Study
by
Yasmin Soltanzadeh-Naderi and Stefan Acosta
Nutrients 2025, 17(1), 147; https://doi.org/10.3390/nu17010147 - 31 Dec 2024
Abstract
Background/Objectives: Acute mesenteric ischemia (AMI) is life-threatening and difficult to diagnose in time. Unlike many cardiovascular diseases, the association between lifestyle factors such as diet, alcohol consumption, and physical activity and AMI is unknown. Methods: This study is a prospective cohort study with
[...] Read more.
Background/Objectives: Acute mesenteric ischemia (AMI) is life-threatening and difficult to diagnose in time. Unlike many cardiovascular diseases, the association between lifestyle factors such as diet, alcohol consumption, and physical activity and AMI is unknown. Methods: This study is a prospective cohort study with 28,098 middle-aged participants with a mean follow-up time of 23.1 years. Baseline characteristics were obtained with questionnaires regarding physical activity, lifestyle, and diet. The primary endpoint was a diagnosis of AMI identified through the Swedish National Patient Register. Follow-up times were decided by the date of diagnosis, death, or end of follow-up, 2022-12-31. Results: The total number of patients with AMI was 140. Current smoking (adjusted hazard ratio [aHR] 3.02, 95% confidence interval [CI] 1.91–4.79) and those with the highest alcohol consumption (aHR 2.53, 95% CI 1.27–5.03) had a higher risk of developing AMI. Participants with high physical activity, 25.1–50.0 metabolic equivalent task hours per week (MET-h/week), had a lower risk (aHR 0.51, 95% CI 0.27–0.95). Diet quality and dietary components did not affect the risk of AMI. Conclusions: Smoking and higher alcohol consumption were associated with higher risk, while physical activity was associated with lower risk of AMI in this prospective cohort. Diet quality and dietary components were less relevant for the prediction of AMI than these traditional risk factors of atherosclerotic disease.
Full article
(This article belongs to the Special Issue Nutritional Strategies for Arterial Health)
Open AccessArticle
Ghrelin Promotes Lipid Uptake into White Adipose Tissue via Endothelial Growth Hormone Secretagogue-Receptor in Mice
by
Hidenori Urai, Tatsuhiko Azegami, Motoaki Komatsu, Rina Takahashi, Yoshiaki Kubota, Kazuhiro Hasegawa, Hirofumi Tokuyama, Shu Wakino, Kaori Hayashi, Takeshi Kanda and Hiroshi Itoh
Nutrients 2025, 17(1), 146; https://doi.org/10.3390/nu17010146 - 31 Dec 2024
Abstract
Background/Objectives: Endothelial peroxisome proliferator-activated receptor gamma (PPARγ) regulates adipose tissue by facilitating lipid uptake into white adipocytes, but the role of endothelial lipid transport in systemic energy balance remains unclear. Ghrelin conveys nutritional information through the central nervous system and increases adiposity,
[...] Read more.
Background/Objectives: Endothelial peroxisome proliferator-activated receptor gamma (PPARγ) regulates adipose tissue by facilitating lipid uptake into white adipocytes, but the role of endothelial lipid transport in systemic energy balance remains unclear. Ghrelin conveys nutritional information through the central nervous system and increases adiposity, while deficiency in its receptor, growth hormone secretagogue-receptor (GHSR), suppresses adiposity on a high-fat diet. This study aims to examine the effect of ghrelin/GHSR signaling in the endothelium on lipid metabolism. Methods: We compared the effects of ghrelin on adiposity and lipid uptake into adipocytes in wild-type and GHSR-null mice. Transgenic mice expressing GHSR selectively in endothelial cells were also generated and compared with global GHSR-null and wild-type mice. The impact of ghrelin on lipid uptake-related genes was assessed in cultured endothelial cells. Results: Ghrelin increased adiposity and triglyceride clearance in wild-type but not in GHSR-null mice. GHSR-null mice showed higher serum triglyceride after olive oil gavage and lower white adipose tissue (WAT) weight on a high-fat diet, suggesting impaired lipid uptake. Restoring GHSR expression in endothelial cells increased lipoprotein lipase activity, lipid uptake into WAT, and WAT weight. Ghrelin enhanced free fatty acid uptake and the expression of lipid uptake genes in cultured endothelial cells, whereas these effects were absent in GHSR-null mice-derived endothelial cells. Knockdown of PPARγ revealed that ghrelin/GHSR signaling in endothelial cells promoted lipid uptake via endothelial PPARγ. Conclusions: Endothelial GHSR is key for regulating lipid metabolism via PPARγ in response to ghrelin and for the role of endothelium in regulating white adipocyte metabolism. _targeting endothelial ghrelin signaling may be a promising therapeutic approach for managing excessive adiposity and associated metabolic disorders.
Full article
(This article belongs to the Section Lipids)
►▼
Show Figures
Graphical abstract
Open AccessSystematic Review
Therapeutic Potential of Ketogenic Interventions for Autosomal-Dominant Polycystic Kidney Disease: A Systematic Review
by
Donglai Li, Jessica Dawson and Jenny E. Gunton
Nutrients 2025, 17(1), 145; https://doi.org/10.3390/nu17010145 - 31 Dec 2024
Abstract
Background: Recent findings have highlighted that abnormal energy metabolism is a key feature of autosomal-dominant polycystic kidney disease (ADPKD). Emerging evidence suggests that nutritional ketosis could offer therapeutic benefits, including potentially slowing or even reversing disease progression. This systematic review aims to synthesise
[...] Read more.
Background: Recent findings have highlighted that abnormal energy metabolism is a key feature of autosomal-dominant polycystic kidney disease (ADPKD). Emerging evidence suggests that nutritional ketosis could offer therapeutic benefits, including potentially slowing or even reversing disease progression. This systematic review aims to synthesise the literature on ketogenic interventions to evaluate the impact in ADPKD. Methods: A systematic search was conducted in Medline, Embase, and Scopus using relevant Medical Subject Headings (MeSH) and keywords. Studies assessing ketogenic interventions in the management of ADPKD in both human and animal models were selected for data extraction and analysis. Results: Three animal reports and six human studies were identified. Ketogenic diets (KD) significantly slowed polycystic kidney disease (PKD) progression in rats with improved renal function and reduced cystic areas. There was reduced renal fibrosis and cell proliferation. The supplementation of beta-hydroxybutyrate (BHB) in rats also reduced PKD progression in a dose-dependent manner. Human studies (n = 129) on KD in ADPKD reported consistent body mass index (BMI) reduction across trials, with an average weight loss of ∼4 kg. Improvements in blood pressure were also noted. Ketosis was achieved in varying degrees. Effects on kidney function (eGFR) were beneficial. Results for kidney volume were mixed but most studies were underpowered for this outcome. Lipid profiles showed increases in total cholesterol (∼1 mmol/L) and LDL cholesterol (∼0.4 mmol/L) in most studies. Safety concerns such as “keto flu” symptoms, elevated uric acid levels, and occasional kidney stones were noted. Overall feasibility and adherence to the KD were rated positively by most participants. Conclusions: Human studies are promising; however, they have been limited by small sample sizes and short durations. Larger, long-term trials are needed to assess the efficacy, adherence, and safety of ketogenic diets in people with ADPKD.
Full article
(This article belongs to the Special Issue The Therapeutic Potential of the Ketogenic Diet across Diverse Chronic Health Conditions)
►▼
Show Figures
Graphical abstract
Open AccessArticle
COVID-19 Implications on School Dietary Behavior in Chinese College Students: Based on the Longitudinal Assessment of Dietary Records from Intelligent Ordering System
by
Shaojie Liu, Hong Peng, Dantong Gu, Mengyun Luo, Haihong Qian and Yingnan Jia
Nutrients 2025, 17(1), 144; https://doi.org/10.3390/nu17010144 - 31 Dec 2024
Abstract
Objectives: The coronavirus disease 2019 (COVID-19) pandemic has changed the dietary behavior of college students; however, the persistence of the changes in dietary behavior remains uncertain. This study aims to explore the changes in school food consumption and dietary quality of college students
[...] Read more.
Objectives: The coronavirus disease 2019 (COVID-19) pandemic has changed the dietary behavior of college students; however, the persistence of the changes in dietary behavior remains uncertain. This study aims to explore the changes in school food consumption and dietary quality of college students during three distinct COVID-19 periods: pre-epidemic (stage T1), epidemic (stage T2), and post-COVID-19 epidemic (stage T3). Methods: The persistent 6-year data, involving 3,484,081 dietary records from January 2018 to December 2023, for college students were acquired from the “Intelligent Ordering System (IOS)”. School food consumption and total energy intake of each college student per day were evaluated by information on three meals in the IOS combined with the corresponding food database of each dish. The school dietary quality of college students was evaluated by the Chinese Healthy Eating Index (CHEI). Results: In total, 459 college students were included in the T1 period, 530 in the T2 period, and 1316 in the T3 period. At stages T2 and T3, the energy, protein, and fat intakes of college students were higher than those at stage T1 (p < 0.001). Meanwhile, the breakfast energy ratio exhibited a significant decrease (0.27 vs. 0.25), while the lunch (0.37 vs. 0.38) and dinner (0.37 vs. 0.38) energy ratios exhibited varying degrees of increase (p < 0.001). After the COVID-19 pandemic, the components’ score of the CHEI for dark vegetables, red meats, and sodium showed an increase, while tubers exhibited a decrease (p < 0.01). Conclusions: This study provides compelling evidence of the significantly negative impact of the COVID-19 pandemic on school food consumption and dietary quality among Chinese college students. However, the duration of this effect may be limited. There was a certain degree of improvement in the food consumption and school diet quality of college students in China following the conclusion of the epidemic.
Full article
(This article belongs to the Special Issue Nutritional Surveys and Assessment of Unhealthy Eating Behaviors)
►▼
Show Figures
Figure 1
Journal Menu
► ▼ Journal Menu-
- Nutrients Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Topic in
Beverages, Foods, Molecules, Nutrients, Separations, Chemosensors
Advances in Analysis of Food and Beverages
Topic Editors: Anna M. Kaczmarek, Constantinos G. TsiafoulisDeadline: 31 January 2025
Topic in
CIMB, Foods, IJMS, Sci. Pharm., Antioxidants, Nutrients
Nutrients, Food Bioactives, and Functional Foods in Gastrointestinal and Metabolic Disorders
Topic Editors: Samuel Fernández-Tomé, Ortega Moreno LorenaDeadline: 31 May 2025
Topic in
Healthcare, IJERPH, JCM, Nutrients, Sports
Effects of Exercise Behavior and Amount of Exercise on Public Health: How to Overcome Barriers to Increase Adherence
Topic Editors: Joao Gustavo Oliveira Claudino, Paula Alves Monteiro, Ana Carolina Paludo, Helder Fonseca, Enrico Fuini Puggina, Romulo Fernandes, Sílvia Rocha-Rodrigues, Julio Cerca SerraoDeadline: 1 July 2025
Topic in
Analytica, Antioxidants, Biomedicines, Nutrients, Separations, Molecules, IJMS
Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases
Topic Editors: Jun Dang, Tengfei Ji, Xinxin ZhangDeadline: 31 July 2025
Conferences
Special Issues
Special Issue in
Nutrients
Community-Based Strategies for Obesity Prevention: A Nutritional Perspective
Guest Editors: Carmen Pérez-Rodrigo, Javier Aranceta-BartrinaDeadline: 5 January 2025
Special Issue in
Nutrients
Impacts of Micronutrients on Immune System and Inflammatory Diseases
Guest Editor: Renata RamalhoDeadline: 5 January 2025
Special Issue in
Nutrients
The Effects of Dietary Protein, Polysaccharide and Micronutrient Fortification on Disease
Guest Editors: Yongting Luo, Junjie LuoDeadline: 5 January 2025
Special Issue in
Nutrients
Nutrition, Metabolites, and Human Health — 2nd Edition
Guest Editor: Christopher PapandreouDeadline: 5 January 2025
Topical Collections
Topical Collection in
Nutrients
Connection between Microbiome, Lifestyle and Diet
Collection Editors: Eva Untersmayr, Peter M. Abuja
Topical Collection in
Nutrients
Clinical Nutrition in Kidney Disease
Collection Editor: Piergiorgio Bolasco
Topical Collection in
Nutrients
Nutritional Epidemiology among Chinese Populations
Collection Editors: Liang Wang, Gangqiang Ding, Xinyin Jiang
Topical Collection in
Nutrients
Bioactive Peptides: Challenges and Opportunities
Collection Editor: Carmen LammiConference Reports
Nutrients 2024, 16(15), 2528; https://doi.org/10.3390/nu16152528
Nutrients 2024, 16(8), 1157; https://doi.org/10.3390/nu16081157